T. Rowe Price Investment Management, Inc. Repligen Corp Transaction History

T. Rowe Price Investment Management, Inc.

$164 Billion
Q3 2025

A detailed history of T. Rowe Price Investment Management, Inc. transactions in Repligen Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 572,078 shares of RGEN stock, worth $87.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

572,078

Previous 559,579 2.23%

Holding current value

$87.2 Million

Previous $69.6 Million 9.87%

% of portfolio

0.05%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$111.43 - $134.0 $1.39 Million - $1.67 Million	12,499 Added 2.23%	572,078 $76.5 Million
Q2 2025 Aug 14, 2025	BUY	$108.89 - $145.23 $32.5 Million - $43.4 Million	298,731 Added 114.52%	559,579 $69.6 Million
Q1 2025 May 14, 2025	BUY	$127.24 - $174.24 $13 Million - $17.7 Million	101,791 Added 64.0%	260,848 $33.2 Million
Q4 2024 Feb 14, 2025	BUY	$123.41 - $160.92 $16.2 Million - $21.1 Million	131,347 Added 474.01%	159,057 $22.9 Million
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $57.8 Million - $80.8 Million	-482,906 Reduced 94.57%	27,710 $4.12 Million

Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $10.1 Million - $15.4 Million	84,102 Added 19.72%	510,616 $64.4 Million
Q1 2024 May 15, 2024	BUY	$170.78 - $208.42 $3.95 Million - $4.83 Million	23,152 Added 5.74%	426,514 $78.4 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $13.7 Million - $22.3 Million	120,080 Added 42.39%	403,362 $72.5 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $487,672 - $620,256	3,514 Added 1.26%	283,282 $45 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $30.9 Million - $40.2 Million	223,187 Added 394.46%	279,768 $39.6 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $1.37 Million - $1.77 Million	8,910 Added 18.69%	56,581 $9.53 Million
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $700,517 - $951,275	4,313 Added 9.95%	47,671 $8.07 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $6.96 Million - $11.1 Million	43,358 New	43,358 $8.11 Million

Others Institutions Holding RGEN

# of Institutions

523

Shares Held

58.9M

Call Options Held

323K

Put Options Held

667K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.46B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.

Account

T. Rowe Price Investment Management, Inc. Repligen Corp Transaction History